There was 100% overall survival in neuroblastoma xenograft models NB-1, NB-SD, COG-N-424x, and NGP ALK WT, and 40% overall survival in SK-N-AS after treatment with CDX0239-PBD (Fig. 7A). Here, ALK is linked to neuroblastoma.